Skip to content

Clinical trials

Completed Rare Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rare Diseases Status: Completed Country / region: United Kingdom Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20133
20151
20161
20171
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Associazione Angela Serra per la ricerca sul cancro2
Ultragenyx Pharmaceutical Inc2
Amgen1
Boston University1
Laboratoire français de Fractionnement et de Biotechnologies1
NightstaRx Ltd, a Biogen Company1
Novartis Pharmaceuticals1
Sanifit Therapeutics S. A.1
University College, London1
Zymenex A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rare Diseases12
Metabolic Diseases2
Ataxia1
Calcinosis1
Calciphylaxis1
Calcium Metabolism Disorders1
Cystinosis1
Dysostoses1
Genetic Diseases, Inborn1
Hearing Loss1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.